Erlotinib and gefitinib for elderly patients with advanced non-small-cell lung cancer.

MLA

Passaro, Antonio, et al. “Erlotinib and Gefitinib for Elderly Patients with Advanced Non-Small-Cell Lung Cancer.” Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 5, June 2014, pp. 646–50. EBSCOhost, https://doi.org/10.2174/187152061405140501101624.

APA

Passaro, A., Alesini, D., Pochesci, A., & Cortesi, E. (2014). Erlotinib and gefitinib for elderly patients with advanced non-small-cell lung cancer. Anti-Cancer Agents in Medicinal Chemistry, 14(5), 646–650. https://doi.org/10.2174/187152061405140501101624

Chicago

Passaro, Antonio, Daniele Alesini, Alessia Pochesci, and Enrico Cortesi. 2014. “Erlotinib and Gefitinib for Elderly Patients with Advanced Non-Small-Cell Lung Cancer.” Anti-Cancer Agents in Medicinal Chemistry 14 (5): 646–50. doi:10.2174/187152061405140501101624.